Description
Tratamiento de leucemia linfoblástica aguda (LLA) de precursores B
PRINCIPIO ACTIVO: BISMUTO SUBSALICILATO - MAGNESIO HIDROXIDO - CALCIO CARBONATO
Conservar a temperatura ambiente entre 15 °C y 25 °C
PRINCIPIO ACTIVO: CICLOBENZAPRINA - CLONIXINATO DE LISINA
FORMA FARMACÉUTICA: 1 FORMULA LACTEA
PODOFILIA N2 250MG SOL 5ML ALUMINIO Y MAGNESIO Tratamiento de leucemia linfoblástica agudaPRINCIPIO ACTIVO: PODOFILIA 25% DOSIS: 5 ML FORMA FARMACUTICA: 1 SUSPENSION PRESENTACIN: 1 FRASCO
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
